RIPK3 and neoplasm: Analysis of TCGA tumors revealed that patient samples showed high levels of RIP3. Although this expression could potentially be from stromal or immune cells in the tumors, we did not find any correlations with other markers of stromal or immune cells, suggesting it originated in the tumor cells.